Latest Investment News

Arena REIT has announced its December 2025 quarter distribution of 4.8125 cents per stapled security, reflecting steady income from its social infrastructure portfolio. The distribution includes components relevant for tax purposes, underscoring the REIT’s ongoing compliance and investor transparency.

Arcadia Minerals has secured a binding term sheet with Hongkong Xinhai Mining Services, granting Xinhai an exclusive option to advance the Swanson Tantalum Project in Namibia towards production through a strategic partnership and investment.

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.

F.F.I. Holdings anticipates a modest decline in half-year profit, citing one-off lease expenses despite steady food operations.

CurveBeam AI has received the first A$4 million tranche of a planned A$10 million strategic investment from a leading Chinese orthopaedic device company, marking a significant step in its expansion into the Chinese market.

Brightstar Resources has successfully raised $180 million through a $175 million institutional placement and a $5 million share purchase plan, fully funding its Goldfields development and advancing the Sandstone project towards a final investment decision.

Fortuna Metals has confirmed significant high-grade rutile mineralisation across broad areas of its Mkanda project in Malawi, with 675 drill holes completed and assays pending for the majority. The discovery positions the company alongside a world-class deposit and taps into surging demand for titanium in robotics.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Barton Gold Holdings has initiated an 8,000m drilling campaign at its Challenger Gold Project, aiming to upgrade resources and deliver a Definitive Feasibility Study by mid-2026. This move sets the stage for restarting the Central Gawler Mill and advancing multiple regional assets.

Taiton Resources has completed a significant placement of nearly 12 million shares to Singapore’s GEMS Strategic Resource Fund, bolstering its capital position and signalling confidence from a reputable international investor.

Hawsons Iron Limited has secured $2.2 million through a discounted share placement, accompanied by free attaching options, to advance key studies and optimisations for its iron project in New South Wales.